Mac-2结合蛋白糖基化异构体在慢性肝病诊断中的作用

杨以良; 崔园园; 胡月; 徐洪芹; 潘煜

doi:10.3969/j.issn.1001-5256.2016.12.036

Mac-2结合蛋白糖基化异构体在慢性肝病诊断中的作用

DOI: 10.3969/j.issn.1001-5256.2016.12.036

吉林大学第一医院肝胆胰内科

基金项目:

吉林大学第一医院青年发展基金(JDYY52015025)；

详细信息

中图分类号: R575
计量
- 文章访问数: 2318
- HTML全文浏览量: 18
- PDF下载量: 512
- 被引次数: 0
出版历程
- 出版日期: 2016-12-20

Role of the Mac-2 binding protein glycosylation isomer in diagnosis of chronic liver diseases

Research funding:

摘要

摘要: Mac-2结合蛋白（M2BP）是存在于胞浆、组织液和血浆中的一类糖蛋白,可由多种组织器官分泌。Mac-2结合蛋白糖基化异构体（M2BPGi）由肝星状细胞合成,简述了M2BPGi在慢性肝病中的研究现状,发现血清M2BPGi水平有助于提高肝脏病变诊断、监测的特异度和敏感度,较其他无创方法具有一定的优势,有望成为肝脏病变诊断的新型生物学标志物。
- 肝疾病 /
- 生物学标记 /
- 糖蛋白类 /
- 诊断 /
- 综述
Abstract: Mac- 2 binding protein is a type of glycoprotein which exits in cytoplasm,interstitial fluid,and plasma and is secreted by a variety of tissues and organs. Mac- 2 binding protein glycosylation isomer( M2BPGi) is synthesized by hepatic stellate cells. This article briefly introduces the research advances in the role of M2 BPGi in chronic liver diseases and finds out that the serum level of M2 BPGi helps to increase the specificity and sensitivity of the diagnosis and monitoring of liver diseases,has certain advantages over other noninvasive methods,and may become a new biological marker for the diagnosis of liver diseases.
- liver diseases /
- biological markers /
- glycoproteins /
- diagnosis /
- review

HTML全文

参考文献(25)

[1]OZAKI Y,KONTANI K,TERAMOTO K,et al.Involvement o90K/Mac-2 binding protein in cancer metastases by increased cellular adhesiveness in lung cancer[J].Oncol Rep,2004,12(5):1071-1077.

[2]CHE UNG KJ,TILLEMAN K,DEFORCE D,et al.Usefulness of a novel serum proteome-derived index FI-PRO(fibrosis-protein)in the prediction of fibrosis in chronic hepatitis C[J].Eur J Gastroentero Hepatol,2011,23(8):701-710.

[3]ITO K,KUNO A,IKEHARA Y,et al.LecT-hepa,a glycomarker derived from multiple lectins,as a predictor of liver fibrosis in chronic hepatitis C patients[J].Hepatology,2012,56(4):1448-1456.

[4]KUNO A,IKEHARA Y,TANAKA Y,et al.A serum'sweetdoughnut'protein facilitates fibrosis evaluation and therapy assessment inpatients with viral hepatitis[J].Sci Rep,2013,3:1065.

[5]TOSHIMA T,SHIRABE K,IKEGAMI T,et al.A novel serum marker,glycosylated Wisteria floribunda agglutinin-positive Mac-2 binding protein(WFA+-M2BP),for assessing liver fibrosis[J].J Gastroenterol,2015,50(1):76-84.

[6]KUNO A,UCHIYAMA N,KOSEKI-KUNO S,et al.Evanescent-field luorescence-assistedlectin microarray:a new strategy for glycanprofiling[J].Nat Methods,2005,2(11):851-856.

[7]URA K,FURUSYO N,OGAWA E,et al.Serum WFA(+)-M2BP is a non-invasive liver fibrosis marker that can predict the efficacy of direct-acting anti-viral-based triple therapy for chronic hepatitis C[J].Aliment Pharmacol Ther,2015,43(1):114-124.

[8]THEIN HH,YI Q,DORE GJ,et al.Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection:a meta-analysis and meta-regression[J].Hepatology,2008,48(2):418-431.

[9]ISHIDA H,SUETSUGU A,NAKAMURA M,et al.Change in serum levels of new hepatic fibrosis marker“Mac-2 binding protein glycosylation isomer(M2BPGi)”in patients with chronic hepatitis C during the treatment of pegylated interferon and ribavirin[J].Rinsho Byori,2015,63(8):901-906.

[10]MIYAKI E,IMAMURA M,HIRAGA N,et al.Daclatasvir and asunaprevir treatment improves liver function parameters and reduces liver fibrosis markers in chronic hepatitis C patients[J].Hepatol Res,2016,46(8):758-764.

[11]URA K,FURUSYO N,OGAWA E,et al.Serum WFA+-M2BP is a non-invasive liver fibrosis marker that can predict the efficacy of direct-acting anti-viral-based triple therapy for chronic hepatitis C[J].Aliment Pharmacol Ther,2016,43(1):114-124.

[12]KAMADA Y,FUJII H,FUJII H,et al.Serum Mac-2 binding protein levels as a novel diagnostic biomarker for prediction of disease severity and nonalcoholic steato hepatitis[J].Proteomics Clin Appl,2013,7(9-10):648-656.

[13]ABE M,MIYAKE T,KUNO A,et al.Association between Wisteria floribunda agglutinin-positive Mac-2binding protein and the fibrosis stage of non-alcoholic fatty liverdisease[J].J Gastroenterol,2015,50(7):776-784.

[14]DU D,ZHU X,KUNO A,et al.Comparison of LecT-Hepa and FibroS can for assessment of liver fibrosis in hepatitis B virus infected patientswith different ALT levels[J].Clin Chim Acta,2012,413(21-22):1796-1799.

[15] TOSHIMA T,SHIRABE K,IKEGAMI T,et al.A novel serum marker,glycosylated Wisteria floribundaagglutinin-positive Mac-2 binding protein(WFA+-M2BP),for assessing liver fibrosis[J].J Gastroenterol,2015,50(1):76-84.

[16]ICHIKAWA Y,JOSHITA S,UMEMURA T,et al.Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein may predict liver fibrosis and progression to hepatocellular carcinoma in patients with chronic hepatitis B virus infection[J].Hepatol Res,2016.[Epub ahead of print]

[17]NISHIKAWA H,ENOMOTO H,IWATA Y,et al.Serum wisteria floribunda agglutinin-positive mac-2-binding protein for patients with chronic hepatitis B and C:a comparative study[J].JViral Hepat,2016,23(12):977-984.

[18]UMEMURA T,JOSHITA S,SEKIGUCHI T,et al.Serum wisteria floribunda agglutinin-positive mac-2-binding protein level predicts liver fibrosis and prognosis in primary biliary cirrhosis[J].Am J Gastroenterol,2015,110(6):857-864.

[19]NISHIKAWA H,ENOMOTO H,IWATA Y,et al.Impact of serum Wisteria Floribunda agglutinin positive Mac-2-binding protein and serum interferon-γ-inducible protein-10 in primary biliary cirrhosis[J].Hepatol Res,2016,46(6):575-583.

[20]YAMASAKI K,TATEYAMA M,ABIRU S,et al.Elevated serum levels of Wisteria floribunda agglutinin-positive human Mac-2binding protein predict thedevelopment of hepatocellular carcinoma in hepatitis C patients[J].Hepatology,2014,60(5):1563-1570.

[21]FUJIYOSHI M,KUNO A,GOTOH M,et al.Clinicopathological characteristics and diagnostic performance of Wisteria floribunda agglutinin positive Mac-2-binding protein as a preoperative serum marker of liver fibrosis in hepatocellular carcinoma[J].J Gastroenterol,2015,50(11):1134-1144.

[22]YAMASAKI K,TATEYAMA M,ABIRU S,et al.Elevated serum levels of WFA-M2BP predict the development of hepatocellular carcinoma in hepatitis C patients[J].Hepatology,2014,60(5):1563-1570.

[23]HANAI T,SHIRAKI M,OHNISHI S,et al.Impact of serum glycosylated Wisteria floribunda agglutininpositive Mac-2 binding protein levels on liver functionalreserves and mortality in patients with liver cirrhosis[J].Hepatol Res,2015,45(11):1083-1090.

[24]CASSINOTTOC,LAPUYADE B,MOURIES A,et al.Non-invasive assessment of liver fibrosis with impulse elastography:comparison of Supersonic Shear Imaging with ARFI and FibroS can?[J].JHepatol,2014,61(3):550-557.

[25]ASRANI SK.Incorporation of noninvasive measures of liver fibrosis into clinical practice:diagnosis and prognosis[J].Clin Gastroenterol Hepatol,2015,13(12):2190-2204.

施引文献

资源附件(0)

访问统计